CRSP

CRISPR Therapeutics AG

Jun 04 • 11:28AM ET

58.60

+6.52 12.52 %

Healthcare • Biotechnology • Switzerland • Mid • NASD

Peers: BEAM NTLA EDIT BMRN INCY VIR ALNY IONS VRTX JAN

| Held by: ARKK IWM XBI ARKG VXF IWN IBB VTWO SCHA SCHM

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-6.21	Insider Own	7.15%	Shs Outstand	96.39M	Perf Week	3.94%
Market Cap	5.65B	Forward P/E	-	EPS next Y	-3.62	Insider Trans	-3.26%	Shs Float	89.55M	Perf Month	11.87%
Enterprise Value	4.00B	PEG	-	EPS next Q	-1.20	Inst Own	72.73%	Short Float	30.48%	Perf Quarter	2.22%
Income	-568.53M	P/S	1378.51	EPS this Y	24.66%	Inst Trans	0.79%	Short Ratio	14.34	Perf Half Y	13.61%
Sales	4.10M	P/B	3.11	EPS next Y	25.83%	ROA	-23.24%	Short Interest	27.29M	Perf YTD	11.75%
Book/sh	18.83	P/C	2.31	EPS next 5Y	29.57%	ROE	-31.21%	52W High	78.48 -25.33%	Perf Year	54.01%
Cash/sh	25.32	P/FCF	-	EPS past 3/5Y	8.21% -4.10%	ROIC	-22.01%	52W Low	37.02 58.29%	Perf 3Y	-9.85%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	43.09% 37.31%	Gross Margin	-5283.40%	Volatility	4.59% 4.88%	Perf 5Y	-48.27%
Dividend TTM	-	EV/Sales	974.96	EPS Y/Y TTM	-37.55%	Oper. Margin	-13408.29%	ATR (14)	2.87	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	17.96	Sales Y/Y TTM	-89.11%	Profit Margin	-13856.54%	RSI (14)	62.68	Recom	1.88
Dividend Gr. 3/5Y	- -	Current Ratio	17.96	EPS Q/Q	19.13%	SMA20	12.13%	Beta	1.71	Target Price	80.62
Payout	-	Debt/Eq	0.43	Sales Q/Q	68.55%	SMA50	12.52%	Rel Volume	2.46	Prev Close	52.08
Employees	-	LT Debt/Eq	0.42	Earnings	May 04 AMC	SMA200	5.33%	Avg Volume	1.90M	Price	58.60
IPO	Oct 19, 2016	Option/Short	Yes / Yes	EPS/Sales Surpr.	-5.05% -75.96%	Trades		Volume	1,578,718	Change	12.52%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)